ALINA GOVER: Open Payments
NPI 1861449977 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 36 payments from 13 companies in 2025. Trend: 2023 $321 · 2024 $1,023 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $183 |
| AstraZeneca Pharmaceuticals LP | 4 | $145 |
| Amgen Inc. | 4 | $138 |
| Indivior Inc. | 4 | $111 |
| Astellas Pharma US Inc | 5 | $97 |
| Exact Sciences Corporation | 3 | $60 |
| KVK-Tech, Inc. | 1 | $55 |
| ABBVIE INC. | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Alkermes, Inc. | 1 | $26 |
Products named: MOUNJARO, EVENITY, SUBLOCADE, AIRSUPRA, Veozah, FARXIGA, The Cologuard Plus Collection Kit, VRAYLAR.
Industry payments across DE — which companies pay providers there.
